Skip to content

Cattell-Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-­duodenectomy

Cattell-Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato­-duodenectomy:  ­a double blinded multicentred trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52263879
Enrollment
506
Registered
2015-01-15
Start date
2015-04-24
Completion date
Unknown
Last updated
2023-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Cancer, Surgery, Gastroenterology

Interventions

1. Blumgart anastomosis, Re-construction of the pancreatic remnant following pancreato-duodenectomy using a Blumgart method 2. Cattell-Warren anastomosis, Re-construction of the pancre

Sponsors

University of Liverpool
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects meeting all of the following criteria will be considered for this trial: 1. Patients undergoing an elective pancreato duodenectomy for presumed malignancy of the head of the pancreas 2. Ability of the subject to understand the nature and consequences of the trial 3. Ability to provide written informed consent.; Target Gender: Male & Female ; Lower Age Limit 18 years

Exclusion criteria

Exclusion criteria: Subjects with the following criteria will not be entered into this trial: 1. Patients undergoing extended pancreato­duodenectomy 2. Left, central or total pancreatectomy 3. Arterial resection or multi­visceral resection 4. Previous pancreatic resection 5. Surgery for known chronic pancreatitis 6. Recruited to any other pancreatic resection trial. 7. Pregnant women

Design outcomes

Primary

MeasureTime frame
Post-operative pancreatic fistula (POPF); Timepoint(s): Post-operative day 3, 5, 7, discharge and 3 month follow up

Secondary

MeasureTime frame
1. Entry into programs of adjuvant therapy / clinical trials of adjuvant therapy; Timepoint(s): 3, 6 and 12 month follow up; 2. Health economic evaluation; Timepoint(s): Enrolment, discharge ad 3, 6 and 12 month follow up 3. Length of hospital stay; Timepoint(s): Discharge, 3, 6 and 12 month follow up 4. Mortality Rate; Timepoint(s): Death due to any cause during the study period will be recorded 5. Operation time; Timepoint(s): Day of surgery 6. Quality of Life; Timepoint(s): Enrolment, discharge and 3, 6 and 12 month follow up 7. Rate of delayed gastric emptying; Timepoint(s): Post-operative day 3, 5, 7 and discharge 8. Rate of intra and post-operative bleeding; Timepoint(s): day of surgery, post-operative day 3, 5, 7 and discharge 9. Rate of post-operative fluid collections; Timepoint(s): Post-operative day 3, 5, 7, discharge and 3 month follow up 10. Rate of pulmonary infection; Timepoint(s): Discharge and 3 month follow up 11. Rate of re-operation; Timepoint(s): Post-operative day 3, 5, 7, discharge and 3, 6 and 12 month follow up 12. Rate of venous thrombo-embolism; Timepoint(s): Post-operative day 3, 5, 7 and discharge and 3, 6 and 12 month follow up 13. Rate of wound infections; Timepoint(s): Post-operative days 3, 5, 7, discharge and 3, 6 and 12 month follow up

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026